Back to search

A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza

NCT03336619

PHASE3INTERVENTIONAL
Romark Laboratories L.C.
1,030 participants
Started 2018-01-17 · Completed 2019-04-17
Status: Completed (as of 12-23-2025)

Conditions

Influenza

Interventions

DRUG: NitazoxanideDRUG: Placebo

Linked Papers (from SciSciNet-V2)

Total Papers0
Background
0
Result
0
Derived
0
Unknown
0
View on ClinicalTrials.gov

Brief Summary

Trial to evaluate efficacy and safety of nitazoxanide (NTZ) in the treatment of uncomplicated influenza.

No papers linked to this trial in SciSciNet

Visit ClinicalTrials.gov for more information about this study